|
Dr. Starner explores studies of bacteria in pulmonary patients, such as cystic fibrosis, and pulmonary host defense. He is a recent recipient of an EHSRC pilot grant to study the role of nontypeable Haemophilus influenzae infection in viral asthma exacerbations.
Recent Publications
-
Starner TD, Shrout JD, Parsek MR, Appelbaum PA, Kim G. 2008. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and diminish established biofilms. Antimicrob Agents Chemother 52(1):137-145
.
-
Look DC, Chin CL, Manzel LJ, Lehman EE, Humlicek AL, Shi L, Starner TD, Denning GM, Murphy TF and Sethi S. 2006. Modulation of airway inflammation by Haemophilus influenzae isolates associated with chronic obstructive pulmonary disease exaacerbation. Proc Am Thorac Soc 3:482-483.
-
Starner TD, Zhang N, Kim G, Apicella MA, McCray PB Jr. 2006. Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis. Am J Respir Crit Care Med 174(2):213-220.
-
Starner TD, McCray PB Jr: American College of Physicians: American Physiological Society. 2005. Pathogenesis of early lung disease in cystic fibrosis: a window of opportunity to eradicate bacteria. Ann Intern Med. 143(11):816-822.
-
Chin CL, Manzel LJ, Lehmann EE, Humlicek AL, Shi L, Starner TD, Denning GM, Murphy TF, Sethi S, Look DC. 2005. Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med 172(1):85-91.
|
